Nasopharyngeal carcinoma (NPC) has a high incidence rate. It is a major
public health burden in endemic areas. NPC is associated with
considerable morbidity and mortality, so better treatment is needed.
Scutellarin (SL) is an anticancer agent extracted from medicinal plants
and it exerts anti-cancer effects through various signaling pathways.
However, Scutellarin’s underlying anti-proliferative and apoptotic
mechanisms remain largely unknown. Thus, the current study intended to
explore the molecular action of in vitro SL on CNE1 and CNE2 human NPC
cells. MTT assay, DCFH-DA, Rh-123 staining, DAPI staining, flow
cytometry, likewise Western blot analysis were employed to assess the
proliferation and apoptosis Of NPC cells (CNE1 and CNE2) were
administered SL (20 and 30 µM). Possible molecular mechanisms;
intracellular ROS, MMP, cell cycle distributions, cell-cycle regulatory
proteins, and MAPKs/NF-κB signaling were assessed. It was found that SL
could inhibit NPC cells proliferation via enhanced intracellular ROS,
MMP loss, and trigger apoptosis. SL prompted G0/G1 arrest in NPC cells
by subduing cell cycle allied proteins; cyclin D1, CDK4/CDK6, pRB, and
MAPKs/NF-κB signaling. Our investigation provides proof that MAPKs/NF-κB
route is a possible target for treatment and may be essential in the
SL-actions that are mediated against nasopharyngeal carcinoma
malignancy.